11 November 2020 1 Min Read
JSE weaker as investors pore over details of Covid-19 vaccine
Enthusiasm that followed Pfizer’s vaccine breakthrough has faded as details about its production and distribution are assessed
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In